Dual CRISPR/Cas9 correction of compound heterozygous MARS2 mutations in the iPSC line ISMMSi060-A from a patient with COXPD25
Open Access
- 19 June 2026
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 95, 104041
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R21NS130319)
- Icahn School of Medicine at Mount Sinai
- National Institute of Child Health and Human Development (K08HD086827)
This publication has 10 references indexed in Scilit:
- Generation of induced pluripotent stem cell line ISMMSi060-A from a patient with combined oxidative phosphorylation deficiency 25Stem Cell Research, 2025
- The Genetics of Intellectual DisabilityBrain Sciences, 2023
- Mitochondrial dynamics in postmitotic cells regulate neurogenesisScience, 2020
- A clinical primer on intellectual disabilityTranslational Pediatrics, 2020
- Near-optimal probabilistic RNA-seq quantificationNature Biotechnology, 2016
- Novel, Compound Heterozygous, Single-Nucleotide Variants inMARS2Associated with Developmental Delay, Poor Growth, and Sensorineural Hearing LossHuman Mutation, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Genome sequencing identifies major causes of severe intellectual disabilityNature, 2014
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and SynapsesCell, 2004